Magzter GOLD ile Sınırsız Olun

Magzter GOLD ile Sınırsız Olun

Sadece 9.000'den fazla dergi, gazete ve Premium hikayeye sınırsız erişim elde edin

$149.99
 
$74.99/Yıl

Denemek ALTIN - Özgür

Spy series focuses on the wrong lead

Mint Mumbai

|

August 16, 2025

Gaurav Shukla's spy series 'Saare Jahan Se Accha' can't add anything new to the saturated espionage genre

- Uday Bhatia

Spy series focuses on the wrong lead

Saare Jahan Se Accha spends most of its time listing differences between India and Pakistan. But Netflix's new spy series can't help draw attention to a common heritage: language. Characters switch naturally between Hindi, Urdu, Punjabi and English, as so many did in undivided Punjab. The Punjabi in particular—spoken by Pakistani and Indian characters—is mellifluous, flowing off the tongues of the actors, not the same intonations you'd hear in a modern Hindi film. It reminded me of Song of Lahore (2015), Sharmeen Obaid-Chinoy's musical documentary, with the Punjabi session players hitting the consonants in trumpeter Wynton Marsalis' name: "Vin-ttun".

The show, created by Gaurav Shukla, opens with conspiracy theory (the CIA blowing up a plane with Indian nuclear physicist Homi Bhabha on board) and boilerplate spy drama truths (we operate in the shadows, our families don't know what we do). Both are delivered in a flat voiceover by Pratik Gandhi, who plays intelligence agent Vishnu Shankar. After the formation of RAW in 1968, its head, R.N. Kao (Rajat Kapoor), sends Vishnu on a top-secret mission: relocate to Islamabad and sabotage Pakistan's nuclear weapons programme.

Mint Mumbai'den DAHA FAZLA HİKAYE

Mint Mumbai

Mint Mumbai

Gen Alpha will make new rules for their workplace

Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’

time to read

3 mins

December 01, 2025

Mint Mumbai

EC extends electoral roll revision by a week to II Dec; final list on 14 Feb

The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.

time to read

2 mins

December 01, 2025

Mint Mumbai

THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS

These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.

time to read

3 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

Green hydrogen: Fast fashion could help bump up demand

A boom in its use for clean synthetic inputs might make a difference

time to read

3 mins

December 01, 2025

Mint Mumbai

Let's be a bit more selective in using the word 'reforms'

Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.

time to read

3 mins

December 01, 2025

Mint Mumbai

As mid-cap alpha shrinks, should you consider passive strategies?

Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey

time to read

4 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

With $2.2 bn fund, ChrysCap has appetite for riskier bets

MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing

time to read

3 mins

December 01, 2025

Mint Mumbai

GDP growth of 8% plus: How to sustain this pace

Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships

time to read

2 mins

December 01, 2025

Mint Mumbai

INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES

Detection tools today are not universal or consistent across languages

time to read

5 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

APIs to innovation: Bulk drug makers ramp up CDMO bets

Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.

time to read

2 mins

December 01, 2025

Listen

Translate

Share

-
+

Change font size